ADBE Just Beat Estimates and Still Fell 6%. Here’s What the Options Market Is Telling You.
Record revenue, raised guidance, a CFO exit — and the stock drops. The setup is more interesting than the headline.
June 14, 2026
GSK Just Paid $10.6 Billion for This Precision Oncology Bet — Here’s What It Signals
The Nuvalent acquisition is the biggest biopharma deal of the week — and it’s rewriting the playbook for lung cancer investing.